申请人:Hoffmann-La Roche Inc.
公开号:US05304549A1
公开(公告)日:1994-04-19
Compounds of the formula ##STR1## wherein A is the group ##STR2## R.sup.1 is hydrogen, amino, protected amino, acylamino or lower alkyl optionally substituted by aryl, hydroxy, protected hydroxy, amino, protected amino, acylamino, maleimido, succinimido, naphthalimido, 2,3-dihydro-1,3-dioxo-1H-benz[d,e]isoquinol-2-yl, carboxy, protected carboxy, carbamoyl, mono(lower alkyl)carbamoyl, di(lower alkyl)carbamoyl, di(lower alkyl)amino, carboxy-lower alkanoylamino, pyrrolidino or morpholino; R.sup.2 is hydrogen or lower alkyl optionally substituted by aryl, amino, protected amino, di(lower alkyl)- amino, guanidino, carboxyl, protected carboxyl, carbamoyl, mono(lower alkyl) carbamoyl, di(lower alkyl)carbamoyl, di(lower alkoxy)phosphinyl, dihydroxyphosphinyl, pyrrolidino, piperidino or morpholino; R.sup.3 is hydrogen or lower alkyl optionally substituted by hydroxy, protected hydroxy, amino or protected amino; R.sup.4 is hydrogen, hydroxy, lower alkoxy or benzyloxy; and R.sup.5 is hydrogen or halogen and their pharmaceutically acceptable salts, which are useful for the control or prevention of degenerative joint diseases or for the treatment of invasive tumors, atherosclerosis or multiple sclerosis are described.
该化合物的分子式为##STR1##其中A是##STR2##R.sup.1是氢,氨基,保护氨基,酰胺基或者可选地被芳基,羟基,保护羟基,氨基,保护氨基,酰胺基,马来酰亚胺基,琥珀酰亯亚胺基,2,3-二氢-1,3-二氧杂-1H-苯并[d,e]异喹啉-2-基,羧基,保护羧基,氨基甲酰基,单(较低烷基)氨基甲酰基,双(较低烷基)氨基甲酰基,双(较低烷基)氨基,羧基-较低烷酰氨基,吡咯烷基或吗啉基;R.sup.2是氢或者可选地被芳基,氨基,保护氨基,双(较低烷基)-氨基,胍基,羧基,保护羧基,氨基甲酰基,单(较低烷基)氨基甲酰基,双(较低烷基)氨基甲酰基,二(较低烷氧基)膦基,二羟基膦基,吡咯烷基,哌啶基或吗啉基;R.sup.3是氢或者可选地被羟基,保护羟基,氨基或保护氨基取代的较低烷基;R.sup.4是氢,羟基,较低烷氧基或苄氧基;R.sup.5是氢或卤素及其药学上可接受的盐。这些化合物对于控制或预防退行性关节疾病,治疗侵袭性肿瘤,动脉粥样硬化或多发性硬化等方面具有用处。